Please login to the form below

Not currently logged in
Email:
Password:

Orphacol

This page shows the latest Orphacol news and features for those working in and with pharma, biotech and healthcare.

EC sets up expert group on rare diseases

EC sets up expert group on rare diseases

approve a previously-rejected drug - CTRS' Orphacol - earlier this month.

Latest news

  • Court orders EC to approve rejected orphan medicine Court orders EC to approve rejected orphan medicine

    Says CTRS should be allowed to market Orphacol for the treatment of rare bile condition. ... The battle pitched small French pharma company Cell Therapies Research &Services (CTRS) against the Commission and focused on Orphacol (cholic acid), a drug

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
Rare thoughts & outcomes - navigating pathways to better outcomes in rare
...
How to pick the perfect training program for your healthcare professionals
You know your team needs training. But not all training providers and programs are created equal. Last week, we shared the benefits of working with specialist learning and development (L&D)...